Top5 Pharma Companies

Particulars
13-Mar
12-Mar
11-Mar
10-Mar
9-Mar
8-Mar
8,294.58
7,074.73
6,398.73
5,411.68
5,021.64
4,088.56
92.16
97.23
67.64
52.16
61.04
90.66
8,202.42
6,977.50
6,331.09
5,359.52
4,960.60
3,997.90
229.13
148.3
91.64
448.72
355.22
340.31
290.75
-11.24
138.71
265.19
113.55
41.37
8,722.30
7,114.56
6,561.44
6,073.43
5,429.37
4,379.58
3,353.72
2,856.40
3,027.25
2,718.17
2,460.95
2,084.08
211.17
211.32
183.65
92.15
91.71
74.69
969.28
728.21
540.33
289.36
242.86
186.47
564.33
535.49
593.34
457.7
441.35
304.85
Selling and
Administrati
on
Expenses
1,076.99
859.99
693.21
808.17
768.49
707.78
Miscellaneo
us
Expenses
198.54
192.99
111.32
189.34
318.68
49.58
Less: Preoperative
Expenses
Capitalised
6,374.03
5,384.40
5,149.10
4,554.89
4,324.04
3,407.45
2,348.27
1,730.16
1,412.34
1,518.54
1,105.33
972.13
33.38
26.63
12.92
28.3
52.23
17.51
2,314.89
1,703.53
1,399.42
1,490.24
1,053.10
954.62
303.03
282.07
248.03
165.25
151.79
116.26
2,011.86
1,421.46
1,151.39
1,324.99
901.31
838.36
456
277.5
157.7
228.5
101
94
8.5
6.43
INCOME :
Sales
Turnover
Excise
Duty
Net Sales
Other
Income
Stock
Adjustment
s
Total
Income
EXPENDIT
URE :
Raw
Materials
Power &
Fuel Cost
Employee
Cost
Other
Manufacturi
ng
Expenses
Total
Expenditur
e
Operating
Profit
Interest
Gross
Profit
Depreciatio
n
Profit
Before Tax
Tax
Fringe
Benefit tax
Deferred
Tax
Reported
Net Profit
Extraordina
ry Items
Adjusted
Net Profit
Adjst.
below Net
Profit
P&L
Balance
brought
forward
Statutory
Appropriati
ons
Appropriati
ons
P&L
Balance
carried
down
48.75
20
33.3
15
15
36.5
1,507.11
1,123.96
960.39
1,081.49
776.81
701.43
-10
-28.7
-3.42
76.77
-3.09
0.94
1,517.11
1,152.66
963.81
1,004.72
779.9
700.49
3,110.26
2,297.93
1,699.07
954.83
509.9
390.35
347.87
311.63
361.53
337.25
331.88
581.88
4,269.50
3,110.26
2,297.93
1,699.07
954.83
509.9
160.58
160.58
224.81
160.58
155.46
155.46
Preference
Dividend
Equity
Dividend %
100
100
140
100
100
100
18.43
13.67
11.5
13.14
9.65
8.68
18.43
13.67
11.5
13.14
9.65
8.68
110.36
93.93
82.25
73.55
55.86
48.2
Dividend
Earnings
Per ShareUnit Curr
Earnings
Per
Share(Adj)Unit Curr
Book ValueUnit Curr
rawmaterisla
3,353.72
2,856.40
3,027.25
2,718.17
2,460.95
2,084.08
net profit
1,507.11
1,123.96
960.39
1,081.49
776.81
701.43
operating profit
2,348.27
1,730.16
1,412.34
1,518.54
1,105.33
972.13
13-Mar
12-Mar
11-Mar
10-Mar
9-Mar
8-Mar
year
raw materials/ net profit
2.225266 2.541372 3.152105 2.513357
3.16802 2.971187
raw materials/ operating profit1.428166 1.650946 2.143429 1.789989 2.226439 2.143829
13-Mar
12-Mar
11-Mar
10-Mar
9-Mar
8-Mar
year
netprofit/raw materials
0.449385 0.393488 0.317248 0.397874 0.315655 0.336566
operatingprofit/rawmaterila 0.700199 0.605713 0.466542 0.558663 0.449148 0.466455

4
3
2
1
0
7-Mar 8-Mar 9-Mar 10-Mar11-Mar12-Mar13-Mar14-Mar
0.5
0.45
0.4
0.35
0.3
0.25
0.2
0.15
0.1
0.05
0
7-Mar 8-Mar 9-Mar10-Mar11-Mar12-Mar13-Mar14-Mar
Particulars
13-Mar
12-Mar
11-Mar
10-Mar
9-Mar
8-Mar
8,505.80
6,780.20
5,340.10
4,543.80
4,239.80
3,449.70
71.8
40.5
97.3
31.6
80.9
84.5
8,434.00
6,739.70
5,242.80
4,512.20
4,158.90
3,365.20
141.7
81.8
119.6
212.4
101.1
191.1
100.6
104.8
79
117.3
64.1
93.9
8,676.30
6,926.30
5,441.40
4,841.90
4,324.10
3,650.20
2,670.40
2,046.20
1,666.10
1,346.00
1,177.60
1,146.10
282.6
177.5
144.6
104.1
90
77.1
1,138.10
866.1
700.6
490.7
393.6
347.9
362.4
359.4
271.4
471.4
509.3
376.4
Selling and
Administrati
on
Expenses
1,817.10
1,499.00
1,252.30
1,003.70
1,032.10
864.2
Miscellaneo
us
Expenses
273.1
348.6
96.7
102.8
170.9
77.6
Less: Preoperative
Expenses
Capitalised
INCOME :
Sales
Turnover
Excise
Duty
Net Sales
Other
Income
Stock
Adjustment
s
Total
Income
EXPENDIT
URE :
Raw
Materials
Power &
Fuel Cost
Employee
Cost
Other
Manufacturi
ng
Expenses
Total
Expenditur
e
Operating
Profit
Interest
Gross
Profit
Depreciatio
n
Profit
Before Tax
Tax
Fringe
Benefit tax
3
2.5
2
0
1.5
6,543.70
5,296.80
4,131.70
3,518.70
3,373.50
2,889.30
2,132.60
1,629.50
1,309.70
1,323.20
950.6
760.9
66.6
69.2
9.9
16
27.4
14.7
2,066.00
1,560.30
1,299.80
1,307.20
923.2
746.2
312.8
301.1
247.9
222.4
193.7
162
1,753.20
1,259.20
1,051.90
1,084.80
729.5
584.2
414
427.5
132.8
256.5
153.8
62.1
-2.4
11.3
17.7
1
0.5
0
7-Mar
0.7
0.6
Deferred
Tax
Reported
Net Profit
Extraordina
ry Items
Adjusted
Net Profit
Adjst.
below Net
Profit
P&L
Balance
brought
forward
Statutory
Appropriati
ons
Appropriati
ons
P&L
Balance
carried
down
73.7
-80.7
25.7
-15.4
3.5
29.1
1,265.50
912.4
893.4
846.1
560.9
475.3
14.22
9.08
-0.16
-0.38
7.84
-0.26
1,251.28
903.32
893.56
846.48
553.06
475.56
-24.8
-1.5
0.3
2,554.10
2,039.10
1,657.50
1,305.10
509
447.2
307.8
306.3
179.3
121.4
4,361.40
3,604.90
3,139.70
2,554.10
2,039.10
1,657.50
254.8
233.1
190.4
190
105.3
63.1
Preference
Dividend
Equity
Dividend %
300
275
225
225
125
75
71.98
51.57
50.98
48.25
32.25
27.62
71.98
51.57
50.98
48.25
32.25
27.62
458.39
396.1
355.8
350.39
312.3
286.08
Book ValueUnit Curr
0.2
0.1
0
7-Mar 8-Mar
3,139.70
Earnings
Per ShareUnit Curr
Earnings
Per
Share(Adj)Unit Curr
0.5
0.4
3,604.90
Dividend
0.6
rawmaterisla 2,670.40
net profit
year
2,046.20
1,666.10
1,346.00
1,177.60
1,146.10
1,265.50
912.40
893.40
846.10
560.90
475.30
13-Mar
12-Mar
11-Mar
10-Mar
9-Mar
8-Mar
raw materials/
2.110154
net profit2.242657 1.864898 1.590829 2.099483 2.411319
year
13-Mar
netprofit/raw0.473899
materials
12-Mar
11-Mar
10-Mar
9-Mar
8-Mar
0.4459 0.536222 0.628603 0.476308 0.414711

3
2.5
2
1.5
1
0.5
0
8-Mar 9-Mar 10-Mar11-Mar12-Mar13-Mar14-Mar
Particulars
12-Dec
11-Dec
10-Dec
9-Dec
8-Dec
7-Dec
6,331.46
7,818.10
5,608.67
4,742.82
4,416.08
4,275.59
27.91
19.05
15.22
14.73
24.17
51.37
6,303.55
7,799.05
5,593.45
4,728.09
4,391.91
4,224.22
257.16
222.66
1,101.37
659.41
370.28
705.33
49.25
135.72
138.25
58.57
115.59
40.65
6,609.96
8,157.43
6,833.07
5,446.07
4,877.78
4,970.20
2,337.66
2,421.64
2,215.28
2,003.87
2,070.10
1,821.97
230.91
194.98
164.24
136.8
140.68
97.07
1,019.59
860.71
764.3
701.82
580.68
388.8
326.3
266.2
270.27
245.23
242.19
150.32
Selling and
Administrati
on
Expenses
1,766.80
2,736.77
1,059.94
1,044.71
1,225.23
1,437.42
Miscellaneo
us
Expenses
609.84
4,152.72
511.26
64.05
1,937.68
103.78
Less: Preoperative
Expenses
Capitalised
6,291.10
10,633.02
4,985.29
4,196.48
6,196.56
3,999.36
318.86
-2,475.59
1,847.78
1,249.59
-1,318.78
970.84
296.98
299
54.19
39.47
145.83
93.43
21.88
-2,774.59
1,793.59
1,210.12
-1,464.61
877.41
186.16
274.08
228.35
148.2
154.47
103
-164.28
-3,048.67
1,565.24
1,061.92
-1,619.08
774.41
-1.94
-3.31
4.77
5.61
18.54
6.56
3.55
15.52
12.48
INCOME :
Sales
Turnover
Excise
Duty
Net Sales
Other
Income
Stock
Adjustment
s
Total
Income
EXPENDIT
URE :
Raw
Materials
Power &
Fuel Cost
Employee
Cost
Other
Manufacturi
ng
Expenses
Total
Expenditur
e
Operating
Profit
Interest
Gross
Profit
Depreciatio
n
Profit
Before Tax
Tax
Fringe
Benefit tax
6
4
2
0
-27-Mar 8-Mar
-4
-6
-8
-10
-12
-14
-16
0.8
0.6
Deferred
Tax
Reported
Net Profit
Extraordina
ry Items
Adjusted
Net Profit
Adjst.
below Net
Profit
P&L
Balance
brought
forward
Statutory
Appropriati
ons
Appropriati
ons
P&L
Balance
carried
down
6.69
411.74
480.78
-608.34
137.65
-162.34
-3,052.05
1,148.73
571.98
-1,044.80
617.72
-378.9
-3,752.59
141.83
14.03
97.3
24.67
216.56
700.54
1,006.90
557.95
-1,142.10
593.05
-2,368.93
682.87
-253.22
-826.58
216.27
47.12
-0.25
212.64
-1.38
-1.95
448.57
-2,531.27
-2,368.93
682.87
-253.22
-826.58
216.27
Dividend
84.21
317.15
Preference
Dividend
Equity
Dividend %
40
170
26.95
13.6
15.11
26.95
13.6
15.11
45.42
45.6
121.74
94.16
84.24
68.01
Earnings
Per ShareUnit Curr
Earnings
Per
Share(Adj)Unit Curr
Book ValueUnit Curr
0.6
0.4
0.2
0
-0.27-Mar 8-Mar
-0.4
-0.6
-0.8
-1
-1.2
-1.4
net profit
year
2,421.64
2,215.28
-162.34 -3,052.05
1,148.73
13-Mar
12-Mar
raw materials/
-14.3998
net profit-0.79345
12-Mar
2,070.10
1,821.97
571.98 -1,044.80
617.72
10-Mar
1.92846 3.503392
11-Mar
9-Mar
8-Mar
-1.98134 2.949508
10-Mar
9-Mar
8-Mar
netprofit/raw-0.06945
materials -1.26032 0.518548 0.285438
-0.50471
0.33904
year
13-Mar
11-Mar
2,003.87

Particulars
13-Mar
12-Mar
11-Mar
10-Mar
9-Mar
8-Mar
3,266.36
2,733.17
2,285.28
2,538.73
2,551.46
2,116.64
120.05
92.1
76.81
82.67
120.74
140.42
3,146.31
2,641.07
2,208.47
2,456.06
2,430.72
1,976.22
34.97
39.34
34.44
30.11
91.62
123.34
24.18
93.26
31.31
16.46
28.11
16.23
3,205.46
2,773.67
2,274.22
2,502.63
2,550.45
2,115.79
1,720.32
1,483.63
1,126.24
1,228.75
1,241.37
941.76
337.91
271.54
206.65
199.46
180.79
164.1
248.66
207.23
172.81
176
151.13
124.71
223.13
203.88
153.32
169.29
178.12
159.37
Selling and
Administrati
on
Expenses
140.22
128.17
118.35
159.03
165.17
159.08
Miscellaneo
us
Expenses
192.04
200.04
26.36
29.11
13.4
18.97
Less: Preoperative
Expenses
Capitalised
2,862.28
2,494.49
1,803.73
1,961.64
1,929.98
1,567.99
343.18
279.18
470.49
540.99
620.47
547.8
203.82
193.12
70.63
16.61
272.82
24.3
139.36
86.06
399.86
524.38
347.65
523.5
152.17
132
99.91
65.11
74.62
63.59
-12.81
-45.94
299.95
459.27
273.03
459.91
13.46
28.13
18.92
26.02
53.9
2.42
2.4
INCOME :
Sales
Turnover
Excise
Duty
Net Sales
Other
Income
Stock
Adjustment
s
Total
Income
EXPENDIT
URE :
Raw
Materials
Power &
Fuel Cost
Employee
Cost
Other
Manufacturi
ng
Expenses
Total
Expenditur
e
Operating
Profit
Interest
Gross
Profit
Depreciatio
n
Profit
Before Tax
Tax
Fringe
Benefit tax
10
5
0
-57-Mar
-10
-15
-20
-25
-30
-35
-40
-45
0.5
0.4
0.3
Deferred
Tax
Reported
Net Profit
Extraordina
ry Items
Adjusted
Net Profit
Adjst.
below Net
Profit
P&L
Balance
brought
forward
Statutory
Appropriati
ons
Appropriati
ons
P&L
Balance
carried
down
30.51
21.51
-7.81
77.25
-16.15
11.34
0.2
-43.32
-80.91
279.63
363.1
260.74
392.27
0.1
-123.13
-145.87
-3.26
-2.57
-2.04
-10.66
79.81
64.96
282.89
365.67
262.78
402.93
-101.68
786.33
922.78
881.85
755.78
671.17
404.56
55.91
55.54
137.02
237.03
176.13
125.66
687.1
786.33
922.78
881.85
755.78
671.17
47.79
47.79
31.85
31.76
22.33
21.93
Preference
Dividend
Equity
Dividend %
300
300
200
200
150
150
17.23
22.53
17.41
26.58
17.23
22.53
17.41
26.58
116.88
120.35
134.37
136.83
90.74
94.29
Dividend
Earnings
Per ShareUnit Curr
Earnings
Per
Share(Adj)Unit Curr
Book ValueUnit Curr
0
7-Mar
-0.1
1,483.63
1,126.24
1,228.75
1,241.37
941.76
net profit
-43.32
-80.91
279.63
363.10
260.74
392.27
year
13-Mar
12-Mar
11-Mar
10-Mar
9-Mar
8-Mar
raw materials/
-39.7119
net profit-18.3368 4.027608 3.384054
year
13-Mar
12-Mar
11-Mar
4.76095 2.400795
10-Mar
9-Mar
8-Mar
netprofit/raw-0.02518
materials -0.05454 0.248286 0.295504 0.210042 0.416529

10
5
0
-57-Mar 8-Mar 9-Mar10-Mar11-Mar12-Mar13-Mar14-Mar
-10
-15
-20
-25
-30
-35
-40
-45
0.5
0.4
0.3
0.2
0.1
0
-0.1
Particulars
13-Mar
12-Mar
11-Mar
10-Mar
8-Dec
7-Dec
2,476.95
2,300.94
1,758.90
1,853.58
1,438.59
1,236.20
5.77
3.84
3.98
4.48
8.58
14.35
2,471.18
2,297.10
1,754.92
1,849.10
1,430.01
1,221.85
676.33
78.93
17.09
227.26
56.14
82.88
82.95
84.39
-18.41
29.23
-14.02
50.93
3,230.46
2,460.42
1,753.60
2,105.59
1,472.13
1,355.66
1,120.73
906.82
804.28
899.67
662.31
606.03
78.68
66.16
42.6
39.46
36.41
29.72
301.07
218.29
171.94
151.94
139.2
111.5
54.76
43.39
36.87
32.4
27.3
23.29
Selling and
Administrati
on
Expenses
245.56
189.83
180.79
229.28
191.56
173.84
Miscellaneo
us
Expenses
481.18
370.55
384.53
1,243.16
704.73
66.77
Less: Preoperative
Expenses
Capitalised
INCOME :
Sales
Turnover
Excise
Duty
Net Sales
Other
Income
Stock
Adjustment
s
Total
Income
EXPENDIT
URE :
Raw
Materials
Power &
Fuel Cost
Employee
Cost
Other
Manufacturi
ng
Expenses
Total
Expenditur
e
Operating
Profit
Interest
Gross
Profit
Depreciatio
n
Profit
Before Tax
Tax
Fringe
Benefit tax
6
4
2
0
7-Mar
-2
2,281.98
1,795.04
1,621.01
2,595.91
1,761.51
1,011.15
-4
948.48
665.38
132.59
-490.32
-289.38
344.51
154.37
215.36
203.08
231.97
121.67
36.85
794.11
450.02
-70.49
-722.29
-411.05
307.66
80.77
66.31
61.58
71.05
46.03
34.54
713.34
383.71
-132.07
-793.34
-457.08
273.12
175.23
-5.43
25.18
0.87
3.8
3.61
-6
-8
0.8
0.6
Deferred
Tax
Reported
Net Profit
Extraordina
ry Items
Adjusted
Net Profit
Adjst.
below Net
Profit
P&L
Balance
brought
forward
Statutory
Appropriati
ons
Appropriati
ons
P&L
Balance
carried
down
0.6
-84.59
205.14
-112.12
30.45
0.4
622.7
184
-132.07
-794.21
-348.76
213.88
0.2
217.39
-69.59
-292.88
-930.52
-443.83
405.31
253.59
160.81
136.31
95.07
213.88
-20.31
-211.6
-296.76
52
32.16
589.23
12.76
-879.36
194.04
-159.27
-172.43
-343.67
-211.61
-296.76
52
54.79
123.12
Preference
Dividend
0.03
0.22
Equity
Dividend %
100
225
55.97
16.79
17.63
55.97
16.79
17.63
74.66
10.98
-6.74
-10.69
61.89
93.75
Book ValueUnit Curr
-0.6
-1
-343.67
Earnings
Per ShareUnit Curr
Earnings
Per
Share(Adj)Unit Curr
-0.4
-0.8
-172.43
Dividend
0
-0.27-Mar
906.82
804.28
899.67
662.31
606.03
net profit
622.70
184.00
-132.07
-794.21
-348.76
213.88
year
13-Mar
12-Mar
11-Mar
10-Mar
9-Mar
8-Mar
raw materials/
1.799791
net profit 4.92837
-6.0898
-1.13279
12-Mar
11-Mar
10-Mar
9-Mar
8-Mar
netprofit/raw 0.55562
materials 0.202907
-0.16421
-0.88278
-0.52658
0.35292
year
13-Mar
-1.89904 2.833505

6
4
2
0
7-Mar 8-Mar 9-Mar 10-Mar11-Mar12-Mar13-Mar14-Mar
-2
-4
-6
-8
0.8
0.6
0.6
0.4
0.2
0
-0.27-Mar 8-Mar 9-Mar10-Mar11-Mar12-Mar13-Mar14-Mar
-0.4
-0.6
-0.8
-1

Top5 Pharma Companies

Загружено:

Сведения о документе

Исходное описание:

Авторское право

Доступные форматы

Поделиться этим документом

Поделиться или встроить документ

Параметры публикации

Этот документ был вам полезен?

Это неприемлемый материал?

Авторское право:

Доступные форматы

Top5 Pharma Companies

Загружено:

Авторское право:

Доступные форматы

Particulars

2.225266 2.541372 3.152105 2.513357

raw materials/ operating profit1.428166 1.650946 2.143429 1.789989 2.226439 2.143829

0.449385 0.393488 0.317248 0.397874 0.315655 0.336566

operatingprofit/rawmaterila 0.700199 0.605713 0.466542 0.558663 0.449148 0.466455

raw materials/ net profit

raw materials/ net profit

Book ValueUnit Curr

0.4459 0.536222 0.628603 0.476308 0.414711

raw materials/ net profit

raw materials/ net profit

8-Mar 9-Mar 10-Mar11-Mar12-Mar13-Mar14-Mar

raw materials/ net profit

7-Mar 8-Mar 9-Mar10-Mar11-Mar12-Mar13-Mar14-Mar

7-Mar 8-Mar 9-Mar10-Mar11-Mar12-Mar13-Mar14-Mar

raw materials/ net profit

raw materials/ net profit

Book ValueUnit Curr

raw materials/ net profit

raw materials/ net profit

Вам также может понравиться